JULIETA VALENZONA: Open Payments
NPI 1588920243 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,737 in 48 payments from 25 companies in 2025. Trend: 2023 $17 · 2024 $391 · 2025 $1,737
Food & beverage: $1,737
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $302 |
| Stryker Corporation | 1 | $163 |
| Regeneron Healthcare Solutions, Inc. | 5 | $154 |
| Merck Sharp & Dohme LLC | 6 | $128 |
| Janssen Biotech, Inc. | 2 | $126 |
| Gilead Sciences, Inc. | 1 | $122 |
| KYOWA KIRIN, INC. | 1 | $108 |
| Eisai Inc. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| Daiichi Sankyo Inc. | 3 | $71 |
Products named: OPTABLATE, DATROWAY, LIBTAYO, KEYTRUDA, IMFINZI, Trodelvy, POTELIGEO, RYBREVANT.
Industry payments across GA — which companies pay providers there.
